Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03937466 · ClinicalTrials.gov registry record · NA
Reducing the Experience of Menopausal Symptoms Through Temperature
A NA study of Menopause and Hot Flashes, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 38
- Enrollment target
- 1
- Study location
NCT03937466: Completed NA study of Menopause and Hot Flashes, sponsored by Wake Forest University Health Sciences.
NCT03937466 is a NA study of Menopause and Hot Flashes that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 38 participants, below the 9,393-participant average among 54 other Menopause trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03937466, a NA study of Menopause and Hot Flashes, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 38 participants
- Enrollment target
- 1
- Study location
Study Summary
The purposes of this study are to obtain preliminary evidence on the efficacy of a cooling mattress pad in reducing subjective hot flashes for peri and postmenopausal women experiencing menopausal hot flashes, and to obtain preliminary evidence on the efficacy of a cooling mattress pad for improving sleep for peri and postmenopausal women experiencing menopausal hot flashes.
Primary Outcome
Daily diary in which subjects will record the number of daily hot flashes and/or night sweats; reported as mean weekly number.
Conditions Studied
Interventions
- DEVICE Cooling mattress pad
Study Locations (1)
North Carolina
- Wake Forest University Health Sciences - Winston-Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2019-07-30 |
| Est. Completion | 2021-06-04 |
| Phase | NA |
What the finished NCT03937466 record still lists
NCT03937466 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 38 participants, a relatively small participant target, below the 9,393-participant average among 54 other Menopause trials with a reported enrollment target (100% lower).
The record links to 2 conditions, with Menopause appearing as the primary indexed condition, and to 1 intervention - of which Cooling mattress pad is the first listed.
NCT03937466 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT03937466 about?
NCT03937466 is a clinical study titled "Reducing the Experience of Menopausal Symptoms Through Temperature". The purposes of this study are to obtain preliminary evidence on the efficacy of a cooling mattress pad in reducing subjective hot flashes for peri and postmenopausal women experiencing menopausal hot flashes, and to obtain preliminary evidence on the efficacy of a cooling mattress pad for improving...
What is the current status of trial NCT03937466?
This trial is currently completed. It is a NA study. The enrollment target is 38 participants. The study started on 2019-07-30. Estimated completion is 2021-06-04.
What conditions does trial NCT03937466 study?
This clinical trial studies the following conditions: Menopause, Hot Flashes.
What interventions are being tested in trial NCT03937466?
The interventions under investigation include: Cooling mattress pad (DEVICE).
Who is sponsoring clinical trial NCT03937466?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03937466 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Menopause
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03937466's enrollment target sits among peer trials
38 40th of 54 higher than 15 of 54 other Menopause trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Menopause trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Hot Flashes and Neurovascular Function in Women
RECRUITING · NA
-
Efficacy and Safety of Shatavari for Treatment of Menopausal Symptoms in Women: A Randomized, Double-blind, Three-arm, Parallel, Placebo-controlled Study
RECRUITING · NA
-
Improving Sympathetic Activity, Hot Flashes, and Sleep in Midlife Women Using Inspiratory Muscle Strength Training
RECRUITING · NA
-
Exercise Training Intensity and Nitrate Supplementation in Post-Menopausal Females
RECRUITING · NA
-
Depression, Aging, Stress and Heart Health Study
RECRUITING · NA
-
Choline Dose Ranging in Postmenopausal Women
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01684904 · 38 participants · NA
Proton Therapy for Esophageal Cancer
- NCT03310879 · 38 participants · Phase 2
Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Encoding D-Type Cyclins or Amplification of CDK4 or CDK6
- NCT03896269 · 38 participants · Phase 1
CPX-351 in Treating Patients With Relapsed or Refractory High Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
- NCT04085315 · 38 participants · Phase 1
Alisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI